US Food and Drug Administration Office of Women's Health: Promoting Therapeutic Optimization in Women

J Clin Pharmacol. 2020 Dec:60 Suppl 2:S11-S17. doi: 10.1002/jcph.1712.

Authors

Erin M South¹, Rebekah L Zinn², Caroline J Huang¹, Kaveeta P Vasisht¹

Affiliations

¹ Office of Women's Health, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.
² Office of the Chief Scientist, Office of the Commissioner, US Food and Drug Administration, Silver Spring, Maryland, USA.

PMID: 33274515
DOI: 10.1002/jcph.1712

No abstract available

Keywords: clinical trials, FDA policy, gender, sex as a biological variable (SABV); sex differences; women's health.

MeSH terms

Clinical Trials as Topic
Female
Health Policy
Humans
Organizational Policy
Sex Factors
United States
United States Food and Drug Administration
Women's Health*